(4R,5R)-4-Methyl-5-phenyl-2-oxazolidinone 99%

We at Embio believe that technology is the backbone for our success and allows us to achieve a leadership position in all the products we manufacture. With 30+ years of experience in Bacterial, Fungal & Category 1 GMO bio transformation, Embio is focused on creating fully backward integrated GMO biotransformation platforms. We believe that our pipeline of disruptive technologies will help create a first movers’ advantage, thereby creating a potential leadership position in the global market.

Licensed to manufacture Schedule-1, Schedule-2 substances, Embio is a leading global player in the domain of controlled substances, advanced intermediates and chiral molecules for more than 30 years and has demonstrated an impeccable track record in compliance and credibility in this space. Embio’s State of the Art manufacturing facility, approved by US-FDA, PMDA, KFDA, COFEPRIS & WHO-GMP, is located 175 kms from Mumbai at MIDC Mahad, on Mumbai-Goa highway.

Our products and services cater to the stringent requirements of a large clientele in more than 70+ countries with the major share in regulated markets that includes a few top 10 pharmaceutical companies in the world.

Chairman’s message

India has arrived into mainstream pharmaceutical markets around the world with many companies taking their operations worldwide. To grow and compete, Indian companies will have to re-think their current business models and move towards innovation led growth. We are focused on building a life sciences company using bio-transformation as a key technology differentiator.

That is what we are attempting to build here at Embio, using biotransformation as a key technology. The 30 plus years of journey by Embio, from its inception to its evolution, is commendable.

Embio has always leveraged its competencies to retain and grow its position of leadership in the global arena. Embio has been evolving steadily to become a global leader in the life sciences sector with its strategic focus on niche products, patented processes & products, state of the art infrastructure, disruptive technologies and empowered organizational culture. These fundamentals being in place, Embio is poised for a bright future and expected to grow exponentially.

I am confident that Embio will continue to strive to excel and make a positive difference in its growth, profitability, social responsibility as well as customer and employee satisfaction.